Loading provider…
Loading provider…
Radiation Oncology Physician in Stony Brook, NY
NPI: 1336533249Primary Practice Location
SUNY/STONY BROOK UNIVERSITY HOSPITAL
240 Meeting House Ln, Southampton, NY
Primary Employer
Stony Brook Radiation Oncology
cancer.stonybrookmedicine.edu
HQ Phone
Get M.D. Mark's Phone Numberphone_androidMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
New York-Presbyterian Brooklyn Methodist Hospital
Residency • Radiation Oncology
2016 - 2020
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99205New patient office or other outpatient visit, typically 60 minutes | 96 | 96 |
| 2 | 77290Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 95 | 108 |
| 3 | 77263Complex radiation therapy planning | 92 | 101 |
| 4 | 77300Calculation of radiation therapy dose | 83 | 315 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 82 | 118 |
Challenging AJCC 8 Staging for Soft Tissue Sarcoma Using the NCDB.
Authors: Hani Ashamalla, Joyson Kodiyan
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2019-06-12
Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
Authors: Efstratios Koutroumpakis, Paul Hegener, Rachel Grimm
Journal: J Oncol Pract
A Case of a Laryngeal MALT Lymphoma in a Patient with a History of Gastric MALT.
Authors: Kavita Dharmarajan, Richard Bakst, Marita Teng, Joshua Brody
Journal: Case Rep Hematol
Publication Date: 2015-01-18
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Paclitaxel, DRUG: Etoposide, BIOLOGICAL: Durvalumab, DRUG: Pemetrexed Disodium